# clm_9AAE36CED876

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: revenue  
value: 2,104,745,000 United States dollar  
valid_from: 2013-12-31  
valid_to: 2014-12-31  
published: 2014-02-13  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_81193541BA7F  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals revenue: 2,104,745,000 United States dollar", as of 2013-12-31 (until 2014-12-31). Claim clm_9AAE36CED876, https://asof.is/claim/clm_9AAE36CED876, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217614000008/0001532176-14-000008-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:Revenues in 10-K FY2013, filed 2014-02-13  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000153217614000008/0001532176-14-000008-index.htm (primary, SEC EDGAR 10-K FY2013, published 2014-02-13)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 1,378,477,000 United States dollar | valid 2012-12-31 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_9AAE36CED876](/claim/clm_9AAE36CED876.md) | [clm_0B45DD87AE68](/claim/clm_0B45DD87AE68.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.